Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
210.25 EUR | -0.92% |
|
+1.40% | -11.15% |
07-04 | Strong Brand Momentum to Help adidas Weather Tariff Headwinds, Baader Helvea Says | MT |
07-04 | ADIDAS : Warburg Research reiterates its Buy rating | ZD |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 2.23 | 5.76 | 2.16 | 0.91 | 3.95 | |||||
Return on Total Capital | 3.82 | 9.66 | 3.66 | 1.57 | 6.97 | |||||
Return On Equity % | 6.26 | 20.54 | 3.85 | -1.13 | 15.27 | |||||
Return on Common Equity | 6.32 | 20.75 | 3.64 | -2.49 | 15.04 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 49.66 | 50.7 | 47.51 | 47.52 | 50.77 | |||||
SG&A Margin | 45.33 | 41.49 | 44.49 | 46.27 | 46.09 | |||||
EBITDA Margin % | 6.59 | 11.81 | 5.61 | 3.66 | 7.4 | |||||
EBITA Margin % | 4.28 | 9.82 | 3.7 | 1.8 | 5.62 | |||||
EBIT Margin % | 3.76 | 9.37 | 3.25 | 1.31 | 5.16 | |||||
Income From Continuing Operations Margin % | 2.17 | 7.03 | 1.13 | -0.27 | 3.48 | |||||
Net Income Margin % | 2.18 | 9.97 | 2.72 | -0.35 | 3.23 | |||||
Net Avail. For Common Margin % | 2.11 | 6.83 | 1.01 | -0.56 | 3.19 | |||||
Normalized Net Income Margin | 1.75 | 5.26 | 1.14 | -0.05 | 2.37 | |||||
Levered Free Cash Flow Margin | 5.98 | 2.6 | -0.66 | 9.91 | 7.47 | |||||
Unlevered Free Cash Flow Margin | 6.5 | 2.92 | -0.28 | 10.38 | 8.05 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.95 | 0.98 | 1.06 | 1.12 | 1.22 | |||||
Fixed Assets Turnover | 4.01 | 4.51 | 4.61 | 4.58 | 5.08 | |||||
Receivables Turnover (Average Receivables) | 8.61 | 10.21 | 9.51 | 9.61 | 10.91 | |||||
Inventory Turnover (Average Inventory) | 2.36 | 2.49 | 2.37 | 2.14 | 2.45 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.38 | 1.56 | 1.27 | 1.22 | 1.24 | |||||
Quick Ratio | 0.76 | 0.77 | 0.48 | 0.53 | 0.59 | |||||
Operating Cash Flow to Current Liabilities | 0.17 | 0.36 | -0.06 | 0.33 | 0.3 | |||||
Days Sales Outstanding (Average Receivables) | 42.51 | 35.74 | 38.38 | 37.99 | 33.54 | |||||
Days Outstanding Inventory (Average Inventory) | 155.38 | 146.54 | 154.16 | 170.39 | 149.34 | |||||
Average Days Payable Outstanding | 90.47 | 84.8 | 68.89 | 96.58 | 81.1 | |||||
Cash Conversion Cycle (Average Days) | 107.42 | 97.48 | 123.65 | 111.8 | 101.79 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 88.03 | 68.02 | 120.71 | 112.95 | 95.21 | |||||
Total Debt / Total Capital | 46.82 | 40.48 | 54.69 | 53.04 | 48.77 | |||||
LT Debt/Equity | 69.36 | 60.34 | 98.84 | 90.74 | 75.15 | |||||
Long-Term Debt / Total Capital | 36.89 | 35.91 | 44.78 | 42.61 | 38.5 | |||||
Total Liabilities / Total Assets | 68.22 | 64.6 | 73.64 | 72.67 | 71.59 | |||||
EBIT / Interest Expense | 4.55 | 17.93 | 5.34 | 1.75 | 5.53 | |||||
EBITDA / Interest Expense | 12.14 | 28.22 | 14.26 | 8.59 | 10.83 | |||||
(EBITDA - Capex) / Interest Expense | 9.83 | 23.77 | 10.58 | 6.32 | 8.93 | |||||
Total Debt / EBITDA | 2.96 | 1.7 | 3.31 | 4.05 | 2.33 | |||||
Net Debt / EBITDA | 0.92 | 0.46 | 2.86 | 2.97 | 1.28 | |||||
Total Debt / (EBITDA - Capex) | 3.65 | 2.02 | 4.46 | 5.5 | 2.83 | |||||
Net Debt / (EBITDA - Capex) | 1.14 | 0.54 | 3.85 | 4.04 | 1.55 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -16.06 | 15.18 | 6.01 | -4.82 | 10.53 | |||||
Gross Profit, 1 Yr. Growth % | -19.84 | 16.73 | -0.66 | -4.33 | 18.09 | |||||
EBITDA, 1 Yr. Growth % | -59.22 | 110.32 | -49.72 | -35.28 | 123.31 | |||||
EBITA, 1 Yr. Growth % | -69.02 | 146.86 | -60.11 | -51.2 | 239.8 | |||||
EBIT, 1 Yr. Growth % | -72.02 | 168.56 | -63.31 | -58.94 | 336.79 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -77.59 | 222.94 | -82.98 | -122.83 | -1.52K | |||||
Net Income, 1 Yr. Growth % | -78.14 | 389.81 | -71.08 | -112.25 | -1.12K | |||||
Normalized Net Income, 1 Yr. Growth % | -78.36 | 220.74 | -77.16 | -105.18 | -4.93K | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -77.87 | 223.27 | -83.34 | -153.85 | -731.96 | |||||
Accounts Receivable, 1 Yr. Growth % | -25.51 | 11.28 | 16.16 | -24.69 | 26.57 | |||||
Inventory, 1 Yr. Growth % | 7.64 | -8.82 | 48.99 | -24.24 | 10.25 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -13.63 | 5.19 | 2.47 | -10.92 | 11.53 | |||||
Total Assets, 1 Yr. Growth % | 1.8 | 5.15 | -8.32 | -11.21 | 14.62 | |||||
Tangible Book Value, 1 Yr. Growth % | -2.99 | 39.94 | -44.4 | -12.17 | 30.17 | |||||
Common Equity, 1 Yr. Growth % | -5.03 | 16.5 | -33.62 | -8.23 | 19.56 | |||||
Cash From Operations, 1 Yr. Growth % | -47.29 | 114.8 | -117.01 | -649.06 | 14.12 | |||||
Capital Expenditures, 1 Yr. Growth % | -36.62 | 34.24 | 2.02 | -27.98 | 15.43 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -45.98 | -48.94 | -126.84 | -1.28K | -16.71 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -43.86 | -47.27 | -110.13 | -2.46K | -14.24 | |||||
Dividend Per Share, 1 Yr. Growth % | - | 10 | -78.79 | 0 | 185.71 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -4.84 | -5.23 | 10.5 | 0.45 | 2.57 | |||||
Gross Profit, 2 Yr. CAGR % | -6.88 | -6.42 | 7.69 | -2.74 | 6.29 | |||||
EBITDA, 2 Yr. CAGR % | -32.84 | -11.56 | 2.94 | -44.1 | 20.22 | |||||
EBITA, 2 Yr. CAGR % | -45.84 | -12.81 | -0.65 | -57.03 | 29.77 | |||||
EBIT, 2 Yr. CAGR % | -44.34 | -13.6 | -0.61 | -62.54 | 33.91 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -49.85 | -11.82 | -25.85 | -80.28 | 80.11 | |||||
Net Income, 2 Yr. CAGR % | -49.62 | 3.48 | 19.02 | -81.17 | 11.73 | |||||
Normalized Net Income, 2 Yr. CAGR % | -52.09 | -16.46 | -14.3 | -89.81 | 58.18 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -49.59 | -12.26 | -26.61 | -70.05 | 84.48 | |||||
Accounts Receivable, 2 Yr. CAGR % | -9.97 | -8.96 | 13.7 | -6.46 | -2.37 | |||||
Inventory, 2 Yr. CAGR % | 12.98 | -0.93 | 16.55 | 6.24 | -8.61 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 43.2 | -4.69 | 3.82 | -4.46 | -0.32 | |||||
Total Assets, 2 Yr. CAGR % | 16.13 | 3.46 | -1.81 | -9.78 | 0.88 | |||||
Tangible Book Value, 2 Yr. CAGR % | 1.84 | 16.51 | -11.79 | -30.12 | 6.92 | |||||
Common Equity, 2 Yr. CAGR % | 0.6 | 5.18 | -12.06 | -21.95 | 4.75 | |||||
Cash From Operations, 2 Yr. CAGR % | -25.62 | 6.41 | -39.55 | -9.23 | 146.48 | |||||
Capital Expenditures, 2 Yr. CAGR % | -21.24 | -9.11 | 17.03 | -14.28 | -8.82 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -17.21 | -49.9 | -62.88 | 95.73 | 213.46 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -14.36 | -48.02 | -76.83 | 88.82 | 349.4 | |||||
Dividend Per Share, 2 Yr. CAGR % | -5.37 | - | -51.7 | -53.94 | 69.03 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -2.21 | -1.05 | -1.62 | 5.14 | 3.71 | |||||
Gross Profit, 3 Yr. CAGR % | -2.72 | -1.79 | -4.54 | 3.36 | 3.76 | |||||
EBITDA, 3 Yr. CAGR % | -18.79 | -4.72 | -26.69 | -13 | -11.3 | |||||
EBITA, 3 Yr. CAGR % | -25.62 | -10.38 | -32.77 | -22.98 | -13.96 | |||||
EBIT, 3 Yr. CAGR % | -28.79 | -6.16 | -35 | -27.7 | -15.05 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -31.77 | -4.44 | -49.04 | -49.93 | -17.95 | |||||
Net Income, 3 Yr. CAGR % | -26.7 | 7.53 | -32.34 | -44.21 | -28.79 | |||||
Normalized Net Income, 3 Yr. CAGR % | -34.94 | -9.54 | -45.73 | -67.81 | -20.55 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -31.31 | -4.04 | -49.57 | -33.81 | -17.23 | |||||
Accounts Receivable, 3 Yr. CAGR % | -5.27 | -3.38 | -1.25 | -0.89 | 3.46 | |||||
Inventory, 3 Yr. CAGR % | 6 | 5.18 | 13.5 | 0.96 | 7.56 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 31.88 | 29.2 | -2.36 | -1.35 | 0.6 | |||||
Total Assets, 3 Yr. CAGR % | 14.52 | 12.34 | -0.62 | -5.05 | -2.28 | |||||
Tangible Book Value, 3 Yr. CAGR % | 3.28 | 13.22 | -8.95 | -11.92 | -14.02 | |||||
Common Equity, 3 Yr. CAGR % | 2.28 | 5.64 | -9.78 | -10.8 | -10.03 | |||||
Cash From Operations, 3 Yr. CAGR % | -3.39 | 5.92 | -42.25 | 20.96 | -3.04 | |||||
Capital Expenditures, 3 Yr. CAGR % | -17.62 | -6.84 | -5.54 | -0.46 | -5.34 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -3.68 | -31.72 | -59.24 | 25.3 | 47.22 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -1.93 | -29.32 | -69.81 | 23.62 | 45.14 | |||||
Dividend Per Share, 3 Yr. CAGR % | 4.89 | -0.5 | - | -38.44 | -15.37 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 3.25 | 2.81 | 1.19 | -0.45 | 0.04 | |||||
Gross Profit, 5 Yr. CAGR % | 3.83 | 3.42 | -0.02 | -2.17 | -0.44 | |||||
EBITDA, 5 Yr. CAGR % | -1.21 | 7.14 | -12.34 | -22.99 | -11.37 | |||||
EBITA, 5 Yr. CAGR % | -5.2 | 6.96 | -16.59 | -33.18 | -13.46 | |||||
EBIT, 5 Yr. CAGR % | -7.64 | 5.97 | -18.74 | -34.97 | -14.43 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -8.92 | 6.66 | -28.44 | -49.17 | -15.56 | |||||
Net Income, 5 Yr. CAGR % | -7.39 | 15.78 | -11.02 | -46.44 | -17.31 | |||||
Normalized Net Income, 5 Yr. CAGR % | -12.49 | 4.37 | -27.28 | -62.22 | -18.89 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -8.62 | 7.13 | -28.43 | -39.77 | -15.28 | |||||
Accounts Receivable, 5 Yr. CAGR % | -0.8 | -0.09 | 1.9 | -4.63 | -1.7 | |||||
Inventory, 5 Yr. CAGR % | 7.15 | 1.27 | 10.1 | 5.61 | 4.08 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 22.87 | 20.3 | 19.84 | 14.51 | -1.55 | |||||
Total Assets, 5 Yr. CAGR % | 9.55 | 7.84 | 7.68 | 2.91 | -0.02 | |||||
Tangible Book Value, 5 Yr. CAGR % | 11.54 | 13.07 | -3.03 | -6.65 | -2.91 | |||||
Common Equity, 5 Yr. CAGR % | 2.64 | 3.04 | -3.72 | -6.41 | -4.23 | |||||
Cash From Operations, 5 Yr. CAGR % | 6.39 | 18.82 | -19.91 | -0.42 | 0.64 | |||||
Capital Expenditures, 5 Yr. CAGR % | -3.97 | -3.09 | -5.76 | -9.89 | -6.87 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 5.25 | 2.45 | -35.45 | 4.17 | -4.24 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 6.08 | 3.12 | -45.93 | 4.82 | -3.65 | |||||
Dividend Per Share, 5 Yr. CAGR % | 13.4 | 10.53 | -23.08 | -26.88 | - |
- Stock Market
- Equities
- ADS Stock
- Financials adidas AG
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition